Nebenwirkungen · Optison
OPTISON 0.19 mg/ml dispersion for injection · Abschnitt 4.8 · PDF-Seite 4
HOS-087779 · Präparat HOS-083547
Adverse reactions to OPTISON are rare and usually of a non-serious nature. In general, the administration of human albumin has been associated with transient altered taste, nausea, flushing, rash, headache, vomiting, chills and fever. Anaphylactic reactions have been associated with the administration of human albumin products. The reported adverse events following the use of OPTISON in Phase III human clinical studies have been mild to moderate with subsequent full recovery.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2022-06-27T16:57:00Z · SHA-256 9e1f2b7218810ef2caf16bfc26bbe904b753cbc6ffa65a570009b7f38116d8b9 · Passage 6513dbcc131f375ff92836b11804dec3ff09f0c04f3fd425766b5698ee710333 · Zeichen 0–480 im Abschnitt